ArticleCell biology and toxicology2023

CASC9 potentiates gemcitabine resistance in pancreatic cancer by reciprocally activating NRF2 and the NF-κB signaling pathway.

Zhengle Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.